Cardiotoxicity in Hematopoietic Stem Cell Transplant: Keeping the Beat

Julie Kay Baker, Jessica Shank-Coviello, Bin Zhou, Jane Dixon, Ruth McCorkle, Daniel Sarpong, Erin Medoff, Dennis Cooper, Stuart Seropian, Feng Dai

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Abstract

This study describes the incidence and type of cardiac events (CEs) experienced by autologous and allogeneic hematopoietic stem cell transplant patients over a 5-year period at a single institution. A total of 9.8% of patients experienced a CE, and those that experienced a CE had an increased risk of death within 1 year (P < .001).

Original languageEnglish (US)
Pages (from-to)244-251.e4
JournalClinical Lymphoma, Myeloma and Leukemia
Volume20
Issue number4
DOIs
StatePublished - Apr 2020

All Science Journal Classification (ASJC) codes

  • Hematology
  • Oncology
  • Cancer Research

Keywords

  • Bone marrow transplant
  • Cardiac event
  • Leukemia
  • Lymphoma
  • Multiple myeloma

Fingerprint

Dive into the research topics of 'Cardiotoxicity in Hematopoietic Stem Cell Transplant: Keeping the Beat'. Together they form a unique fingerprint.

Cite this